AbbVie Inc.

NYS: ABBV

GO
/marketstate/country/us

Market open

/zigman2/quotes/202428675/composite

$

99.36

Change

+0.48 +0.49%

Volume

Volume 3.42m

Jul 6, 2020, 2:04 p.m.

Real time quotes

/zigman2/quotes/202428675/composite

Previous close

$ 98.88

$ 99.36

Change

+0.48 +0.49%

Day low

Day high

$97.95

$99.86

Open
Open: 99.64

52 week low

52 week high

$62.55

$99.99

Open

Market cap

$174.26B

Average volume

10.43M

P/E ratio

17.57

Rev. per Employee

$1.09M

EPS

5.65

Dividend

1.18

Div yield

4.75%

Ex dividend date

7/14/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/abbv

MarketWatch News on ABBV

  1. How gene therapy and CRISPR are helping to cure blindness

    8:21 a.m. June 26, 2020

    - Hemant Khanna

  2. A Yes Vote for AMD Stock

    7:00 p.m. June 19, 2020

  3. AbbVie Stock Has More Upside, Analyst Says

    12:08 p.m. June 19, 2020

    - Bill Alpert

  4. Recent Dividend Moves Have Been Mixed as Virus Continues to Cloud Picture

    12:05 p.m. June 19, 2020

    - Lawrence C. Strauss

  5. AbbVie Can Withstand Humira’s Decline With New Drugs

    10:29 a.m. June 10, 2020

    - Bill Alpert

  6. AbbVie to pay Genmab $750 mln upfront, up to $3.15 bln in milestone payments as part of cancer collaboration

    6:02 a.m. June 10, 2020

    - Tomi Kilgore

  7. Merger Arbs Are Confident Despite Whispers About Tiffany

    6:30 a.m. June 4, 2020

    - Andrew Bary

  8. Why AbbVie Stock Has Room to Run After Allergan Merger

    10:36 a.m. June 2, 2020

    - Teresa Rivas

  9. Buy Lilly, AbbVie and Merck, J.P. Morgan Says

    9:16 a.m. June 2, 2020

    - Bill Alpert

  10. AbbVie, Ironwood to discontinue experimental IBS drug

    8:51 a.m. May 27, 2020

    - Jaimy Lee

  11. Financial stocks look ripe for dividend investors

    9:03 a.m. May 20, 2020

    - Philip van Doorn

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/abbv

Other News on ABBV

  1. ObsEva down 42% on late-stage linzagolix data

    11:29 a.m. Today

    - Seeking Alpha

  2. Nicholas Ward's Dividend Growth Portfolio: June 2020 Update

    10:00 a.m. Today

    - Seeking Alpha

  3. 4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger

    9:59 a.m. Today

    - Zacks.com

  4. Top 10 Healthcare Stocks For Dividend Growth And Income

    9:01 a.m. Today

    - Seeking Alpha

  5. Royalty Pharma Stock Is Likely to Reach New Highs in the Coming Years

    6:40 a.m. Today

    - InvestorPlace.com

  6. 2020 First Half Portfolio Review

    4:15 p.m. July 5, 2020

    - Seeking Alpha

  7. 3 Reasons AbbVie Could Make You Rich

    10:31 a.m. July 3, 2020

    - Seeking Alpha

  8. Keep an Eye on Royalty Pharma Stock, 2020’s Biggest IPO

    1:02 p.m. July 2, 2020

    - InvestorPlace.com

  9. AbbVie Is Cheap and Pays an Attractive Yield

    12:32 p.m. July 2, 2020

    - InvestorPlace.com

  10. AbbVie: The End Of Suffering

    12:14 p.m. July 2, 2020

    - Seeking Alpha

  11. Top Ranked Income Stocks to Buy for July 2nd

    8:37 a.m. July 2, 2020

    - Zacks.com

  12. What Makes AbbVie (ABBV) a New Strong Buy Stock

    12:00 p.m. July 1, 2020

    - Zacks.com

  13. Best ETFs for 2020: The AdvisorShares Vice ETF Bets Big on Booze

    11:09 a.m. July 1, 2020

    - InvestorPlace.com

  14. Loading more headlines...
/news/pressrelease/company/us/abbv

Press Releases on ABBV

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.